Fareva Amboise

Poce-sur-Cisse, FranceFEI 3000234005

Fareva Amboise is a drug establishment in Poce-sur-Cisse, France, registered with the US FDA under FEI 3000234005. Its registered operations are: Analytical testing, Labelling, Drug manufacture, Packaging. 6 EU/UK GMP certificates are matched to this site, 3 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Analytical testingLabellingDrug manufacturePackaging

GMP documents matched to this site (6)

DocumentAuthorityInspectionSource
2026_HPF_FR_007
GMP certificate
Competent authority of France2 Oct 2025
within 3-year review window
EudraGMDP
2026_HPF_FR_008
GMP certificate
Competent authority of France2 Oct 2025
within 3-year review window
EudraGMDP
25/389926
GMP certificate
Competent authority of France30 Apr 2025
within 3-year review window
EudraGMDP
24/361195
GMP certificate
Competent authority of France13 Oct 2023
outside 3-year review window
EudraGMDP
2023_HPF_FR_175
GMP certificate
Competent authority of France13 Oct 2023
outside 3-year review window
EudraGMDP
2023_HPF_FR_174
GMP certificate
Competent authority of France13 Oct 2023
outside 3-year review window
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.